Fructosamine Reagents Market Strategies and Forecast by 2031

MARKET INTRODUCTION

In a diabetic patient where blood glucose levels are increased abnormally, the concentration levels of fructosamine also increase as fructosamine is formed by a non-enzymatic Maillard reaction between glucose and amino acid residues of proteins. During this glycation process, an intermediate labile Schiff base is produced which is converted to a more stable fructosamine via an Amadori rearrangement. Fructosamine has been known as an early indicator of diabetic control in comparison to other markers such as HbA1c. Red blood cells live for approximately 120 days, HbA1c represents the average blood glucose levels for the previous 2 to 3 months. Conversely, fructosamine has a shorter lifespan which is about 14 to 21 days, reflecting average blood glucose levels from the previous 2 to 3 weeks. Due to the shorter time span of fructosamine, it is also used to evaluate the effectiveness of medication changes and to monitor the treatment of gestational diabetes.

MARKET DYNAMICS

Factors driving the growth of the fructosamine reagents market are the growing prevalence of diabetes across the world, coupled with widespread availability of the fructosamine reagents. However, the economic nature of HbA1C test is expected to hamper the growth of the market. Moreover, increasing per capita expenditure on the evaluating the glucose level testing and rising the adoption of fructosamine reagents for glucose monitoring is anticipated to boost the market growth.

MARKET SCOPE

The "Fructosamine Reagents Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of fructosamine reagents market with detailed market segmentation by disease type and end user. The fructosamine reagents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in fructosamine reagents market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The fructosamine reagents market is segmented on the basis of disease type and end user. Based on disease type, the market is segmented as type 1 diabetes and type 2 diabetes. On the basis of end user, the market is categorized as hospitals, diagnostic laboratories, and specialty clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the fructosamine reagents market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The fructosamine reagents market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting fructosamine reagents market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the fructosamine reagents market in these regions.

MARKET PLAYERS

The report covers key developments in the fructosamine reagents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from fructosamine reagents market are anticipated to have lucrative growth opportunities in the future with the rising demand for fructosamine reagents in the global market. Below mentioned is the list of few companies engaged in the fructosamine reagents market.

The report also includes the profiles of key players in fructosamine reagents market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Randox Laboratories Ltd.
  
•  Sekisui Diagnostics
  
•  Biosystems S.A.
  
•  Kamiya Biomedical Co.
  
•  Sentinel Diagnostics
  
•  Asahi Kasei Pharma Corporation
  
•  Pointe Scientific, Inc.
  
•  Others
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Fructosamine Reagents Report Scope